News
13h
Live Science on MSNOzempic-style drugs treat type 1 diabetes, not only type 2, study findsA clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...
In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.
Dr. Lily Ackermann discussed inpatient diabetes care, focusing on real-world decisions and personalized treatment using ...
Experts speaking at the ADA’s Scientific Sessions supported making CGMs more accessible, but debated their usefulness for ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...
Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...
There's a strong case that healthcare is the most important sector in the stock market. Investors stand to benefit as ...
A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...
Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...
Loyal has a trio of longevity drugs in the works, including two meant to specifically target larger breeds that typically ...
13h
Verywell Health on MSNHow to Count Macros for Your Diet and Fitness GoalsYou can count macronutrients with apps or a written food diary. Learn how to count macros if you’re trying to lose weight or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results